New patent for Novartis drug TAFINLAR

Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…

The post New patent for Novartis drug TAFINLAR appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog